Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device
Phase 1
Completed
- Conditions
- COPD
- Interventions
- Device: Zephir inhaler
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Xiromed LLC
- Target Recruit Count
- 116
- Registration Number
- NCT06254664
- Locations
- 🇺🇸
Vanguard Clinical Research, LLC, Fort Myers, Florida, United States
🇺🇸My Preferred Research LLC, Miami, Florida, United States
🇺🇸Clintex Research Group, Miami, Florida, United States
Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Completed
- Conditions
- COPD
- Interventions
- Combination Product: PlaceboCombination Product: Test Product - Tiotropium Bromide Inhalation Powder 18 mcgCombination Product: Spiriva Handihaler (Tiotropium Bromide) 18 mcg
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Xiromed LLC
- Target Recruit Count
- 335
- Registration Number
- NCT05986591
- Locations
- 🇺🇸
Velocity Clinical Research Anderson, Anderson, South Carolina, United States
🇺🇸Clintex Research Group, Inc., Miami, Florida, United States
🇺🇸Vista Health Research, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath